Propofol treatment in adult refractory status epilepticus. Mortality risk and outcome

Aegerter, 2005, SAPS II revisited, Intensive Care Med., 31, 416, 10.1007/s00134-005-2557-9 Bebin, 1994, New anticonvulsant drugs, focus on flunarizine, fosphenytoin, midazolam and stiripentol, Drugs, 48, 153, 10.2165/00003495-199448020-00003 Bleck, 2005, Refractory status epilepticus, Curr. Opin. Crit. Care, 11, 117, 10.1097/01.ccx.0000157079.72999.87 Chapman, 2001, Status epilepticus, Anaesthesia, 56, 648, 10.1046/j.1365-2044.2001.02115.x Claassen, 2002, Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review, Epilepsia, 43, 146, 10.1046/j.1528-1157.2002.28501.x Cremer, 2009, The propofol infusion syndrome: more puzzling evidence on a complex and poorly characterized disorder, Crit. Care, 13, 1012, 10.1186/cc8177 Engelsen, 2008, POLG1 mutations cause a syndromic epilepsy with occipital lobe predilection, Brain, 131, 818, 10.1093/brain/awn007 Federman, 2009, Refractory metabolic acidosis as a complication of high-dose midazolam infusion for pediatric status epilepticus, Clin. Neuropharmacol., 32, 340, 10.1097/WNF.0b013e3181b77d07 Fodale, 2008, Propofol infusion syndrome: an overview of a perplexing disease, Drug Saf., 31, 293, 10.2165/00002018-200831040-00003 Ho, 2008, The use of propofol for medium and long-term sedation in critically ill adult patients: a meta-analysis, Intensive Care Med., 34, 1969, 10.1007/s00134-008-1186-5 Holtkamp, 2003, The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists, J. Neurol. Neurosurg. Psychiatry, 74, 1095, 10.1136/jnnp.74.8.1095 Holtkamp, 2007, The anaesthetic and intensive care of status epilepticus, Curr. Opin. Neurol., 20, 188, 10.1097/WCO.0b013e328042bacb Iyer, 2009, Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience, Crit. Care Med., 37, 3024, 10.1097/CCM.0b013e3181b08ac7 Kreft, 2008, Refractory status epilepticus in two children with lethal rhabdomyolysis, Ugeskr Laeger, 170, 3339 Kumar, 2005, The syndrome of irreversible acidosis after prolonged propofol infusion, Neurocrit. Care, 3, 257, 10.1385/NCC:3:3:257 Lowenstein, 1988, Barbiturate anesthesia in the treatment of status epilepticus: clinical experience with 14 patient, Neurology, 38, 395, 10.1212/WNL.38.3.395 Mayer, 2002, Refractory status epilepticus: frequency, risk factors, and impact on outcome, Arch. Neurol., 59, 205, 10.1001/archneur.59.2.205 Meierkord, 2006, EFNS guidelines for the treatment of status epilepticus, Eur. J. Neurol., 13, 445, 10.1111/j.1468-1331.2006.01397.x Meierkord, 2010, EFNS guidelines for the treatment of status epilepticus in adults, Eur. J. Neurol., 17, 348, 10.1111/j.1468-1331.2009.02917.x Meldrum, 1978, Physiological changes during prolonged seizures and epileptic brain damage, Neuropadiatrie, 9, 203, 10.1055/s-0028-1091481 Niermeijer, 2003, Propofol in status epilepticus: little evidence, many dangers?, J. Neurol., 250, 1237, 10.1007/s00415-003-0180-7 Parent, 1994, Treatment of refractory generalized status epilepticus with continuous infusion of midazolam, Neurology, 44, 1837, 10.1212/WNL.44.10.1837 Parviainen, 2002, High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit, Neurology, 22, 1249, 10.1212/01.WNL.0000032253.88378.D7 Parviainen, 2006, Propofol in the treatment of refractory status epilepticus, Intensive Care Med., 32, 1075, 10.1007/s00134-006-0154-1 Parviainen, 2007, Propofol and barbiturates for the anesthesia of refractory convulsive status epilepticus: pros and cons, Neurol. Res., 29, 667, 10.1179/016164107X240044 Prasad, 2001, Propofol and midazolam in the treatment of refractory status epilepticus, Epilepsia, 42, 380, 10.1046/j.1528-1157.2001.27500.x Reynolds, 2000, Hyperlactatemia, increased osmolar gap, and renal dysfunction during continuous lorazepam infusion, Crit. Care Med., 28, 1631, 10.1097/00003246-200005000-00063 Roberts, 2009, Incidence of propofol-related infusion syndrome in critically ill adults: a prospective, multicenter study, Crit. Care, 13, R169, 10.1186/cc8145 Rossetti, 2005, Refractory status epilepticus: effect of treatment aggressiveness on prognosis, Arch. Neurol., 62, 1698, 10.1001/archneur.62.11.1698 Rossetti, 2009, Drug treatment of refractory status epilepticus, Rev. Neurol. (Paris), 165, 373, 10.1016/j.neurol.2008.12.003 Stecker, 1998, Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings, Epilepsia, 39, 18, 10.1111/j.1528-1157.1998.tb01269.x Strand, 2008, Severity scoring in the ICU: a review, Acta Anaesthesiol Scand., 52, 467, 10.1111/j.1399-6576.2008.01586.x Ulvi, 2002, Continous infusion of midazolam in the treatment of refractory generalized convulsive status epilepticus, Neurol. Sci., 23, 177, 10.1007/s100720200058 Vanlersberghe, 2008, Propofol. Handb Exp. Pharmacol., 182, 227, 10.1007/978-3-540-74806-9_11 Yaffe, 1993, Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus, Neurology, 43, 895, 10.1212/WNL.43.5.895 Yahwak, 2008, Subak-Sharpe S determination of a lorazepam dose threshold for using the osmol gap to monitor for propylene glycol toxicity, Pharmacotherapy, 28, 984, 10.1592/phco.28.8.984